These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1676509)

  • 1. Neurotransmitters and neuropeptides in Alzheimer's disease.
    McDonald WM; Nemeroff CB
    Psychiatr Clin North Am; 1991 Jun; 14(2):421-42. PubMed ID: 1676509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The neurochemistry of Alzheimer's disease.
    Engelborghs S; De Deyn PP
    Acta Neurol Belg; 1997 Jun; 97(2):67-84. PubMed ID: 9246374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neuromodulators and Alzheimer's disease].
    Vallet PG; Bouras C
    Encephale; 1988; 14(5):345-51. PubMed ID: 2463900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neurotransmitter anomalies in Alzheimer's disease].
    Berger B
    Rev Neurol (Paris); 1984; 140(10):539-52. PubMed ID: 6150545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neuropeptides and Alzheimer's disease].
    Jiménez A; Astarloa R; Morales B
    Neurologia; 1991 Jan; 6(1):17-24. PubMed ID: 1677810
    [No Abstract]   [Full Text] [Related]  

  • 6. Galanin immunoreactivity is increased in the nucleus basalis of Meynert in Alzheimer's disease.
    Beal MF; MacGarvey U; Swartz KJ
    Ann Neurol; 1990 Aug; 28(2):157-61. PubMed ID: 1699471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reciprocal changes in corticotropin-releasing factor (CRF)-like immunoreactivity and CRF receptors in cerebral cortex of Alzheimer's disease.
    De Souza EB; Whitehouse PJ; Kuhar MJ; Price DL; Vale WW
    Nature; 1986 Feb 13-19; 319(6054):593-5. PubMed ID: 3003585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Alzheimer's disease and neurotransmitters].
    Nakamura S
    Tanpakushitsu Kakusan Koso; 1991 Jan; 36(1):30-40. PubMed ID: 1672465
    [No Abstract]   [Full Text] [Related]  

  • 9. Neuropathologic changes in Alzheimer's disease.
    Wenk GL
    J Clin Psychiatry; 2003; 64 Suppl 9():7-10. PubMed ID: 12934968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Abnormalities of neurotransmitters in Alzheimer's disease. Neurotransmitters and receptors].
    Ogawa N; Sato H
    Nihon Rinsho; 1988 Jul; 46(7):1496-501. PubMed ID: 2851665
    [No Abstract]   [Full Text] [Related]  

  • 11. [Studies of cerebrospinal fluid diagnosis in Alzheimer's disease: a review of the literature and of current developments].
    van Gool WA; Bolhuis PA
    Tijdschr Gerontol Geriatr; 1992 Dec; 23(6):212-6. PubMed ID: 1362298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neurotransmitters in Alzheimer's disease].
    Manzano-Palomo S; De la Morena-Vicente MA; Barquero MS
    Rev Neurol; 2006 Mar 16-31; 42(6):350-3. PubMed ID: 16575771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neurotransmitters in Alzheimer's disease].
    Kristensen MO
    Ugeskr Laeger; 1990 Jul; 152(30):2165-8. PubMed ID: 1975961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurotransmitters in the human and nonhuman primate basal ganglia.
    Haber SN
    Hum Neurobiol; 1986; 5(3):159-68. PubMed ID: 2876974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurotransmitter deficits in Alzheimer's disease and in other dementing disorders.
    Mann DM; Yates PO
    Hum Neurobiol; 1986; 5(3):147-58. PubMed ID: 2876973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatostatin, Alzheimer's disease and cognition: an old story coming of age?
    Epelbaum J; Guillou JL; Gastambide F; Hoyer D; Duron E; Viollet C
    Prog Neurobiol; 2009 Oct; 89(2):153-61. PubMed ID: 19595735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A postmortem study of amino acid neurotransmitters in Alzheimer's disease.
    Ellison DW; Beal MF; Mazurek MF; Bird ED; Martin JB
    Ann Neurol; 1986 Nov; 20(5):616-21. PubMed ID: 2878639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiology and pathophysiology of excitatory amino acid neurotransmitter systems in relation to Alzheimer's disease.
    Foster AC
    Adv Neurol; 1990; 51():97-102. PubMed ID: 2152999
    [No Abstract]   [Full Text] [Related]  

  • 19. Striatal monoaminergic terminals in Lewy body and Alzheimer's dementias.
    Suzuki M; Desmond TJ; Albin RL; Frey KA
    Ann Neurol; 2002 Jun; 51(6):767-71. PubMed ID: 12112084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alzheimer's disease: biological diagnosis.
    Ebinger G; Herregodts P; Michotte Y; Vanderheyden P; Vauqelin G
    Acta Neurol Belg; 1989; 89(3-4):132-4. PubMed ID: 2516958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.